Neoadjuvant Therapy for Locally Advanced Rectal Cancer

EARLY_PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

August 1, 2026

Study Completion Date

August 1, 2027

Conditions

Colorectal Cancer

Interventions

DRUG

Anlotinib hydrochloride,Penpulimab

Penpulimab 200mg IV D1 Anlotinib 12mg P.O. QD D1-14

Trial Locations (1)

Jiangsu Provincial People's Hospital, Nanjing

All Listed Sponsors

lead

The First Affiliated Hospital with Nanjing Medical University

OTHER